Every third person suffers from a brain-related disorder – be it Alzheimer’s, Parkinson, attention deficiency hyperactivity disorder (ADHD), chronic pain or depression. But there is no definite diagnosis to document the effects of treatment, which is still based lot on guesswork, resulting in low success rates at high costs.
An Israeli company – EIMindA, has developed a technology, which promises in clinical studies of brain-related disorders. The company claims the non-invasive brain network activation (BNA) technology helps in diagnostics in a way no other existing technology can do.
The procedure is simple and painless. Continue Reading »








